Butibufen

CAS : 55837-18-8

Ref. 3D-FB19394

Informations sur le produit

• Nom: Butibufen
• Synonymes: a-Ethyl-4-(2-methylpropyl)benzeneacetic acid2-(4-Isobutylphenyl)butyric acidDF 1903Y, 2-(4-Isobutylphenyl)buttersaeure, 2-(4-Isobutylphenyl)butyric acid, 2-(p-Isobutylphenyl)butyrate, 2-(p-Isobutylphenyl)butyric acid, 2-[4-(2-Methylpropyl)Phenyl]Butanoic Acid, Benzeneacetic acid, α-ethyl-4-(2-methylpropyl)-, Brn 2261197, Butibufen [INN], Butibufene, Butibufene [INN-French], Butibufeno, Butibufeno [INN-Spanish], Butibufenum, Butibufenum [INN-Latin], Butilopan, Butyric acid, 2-(4-isobutylphenyl)-, Df 1903Y, Ff 106, Unii-Jss1Tem917, alpha-Ethyl-4-(2-methylpropyl)benzeneacetic acid, α-Ethyl-4-(2-methylpropyl)benzeneacetic acid

Description

Butibufen is a new anti-inflammatory drug that has been shown to inhibit the proliferation of tumor cells in vitro and in vivo. It inhibits the growth of cancer cells by inhibiting the actin cytoskeleton, which is necessary for cell migration and invasion. Butibufen also decreases ATP production and induces autophagy, which plays an important role in maintaining cellular homeostasis. The anticancer activity of butibufen may be due to its ability to inhibit the production of reactive oxygen species and reduce oxidative stress.

3-desacetylcefotaxime potassium: 3DCTKP is an antibacterial agent that belongs to the group of β-lactam antibiotics. It is a prodrug that is hydrolyzed in vivo to cefotaxime, its active form. 3-Desacetylcefotaxime potassium has antagonistic effects against clostridium and can be used for the treatment of infections caused by this

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 220.31 g/mol
• Formule: C₁₄H₂₀O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder
• InChI: InChI=1S/C14H20O2/c1-4-13(14(15)16)12-7-5-11(6-8-12)9-10(2)3/h5-8,10,13H,4,9H2,1-3H3,(H,15,16)
• Code InChI: InChIKey=UULSXYSSHHRCQK-UHFFFAOYSA-N
• SMILES: CCC(C(=O)O)c1ccc(CC(C)C)cc1